Jorge Cuadros OD PhD
        Tara Seymour
Significance of Broader Blindness
Prevention in Our Clinics
 Diabetic retinopathy is the main cause of
  blindness in working age adults, but not
  in all adults.
 More people will become blind from
  macular degeneration and glaucoma.
 The majority of blindness could be
  prevented with early intervention.
 Many sight-threatening conditions have
  been detected and referred through
  EyePACS
EyePACS Referrals
 8.21% of all EyePACS consults resulted in
  referral for sight-threatening diabetic retinopathy
 7.83% of all EyePACS consults resulted in
  referral for other sight-threatening conditions
     Glaucoma
     Cataract
     Maculopathy
     Papillopathy (optic nerve)
     Pigmented lesions
     Retinal degeneration
How Does Your Clinic Handle Eye
Referrals?
 No time frame given – all eye referrals
  generally treated the same
 Urgent referrals (within 2 days) made with
  sudden decreased vision or ocular pain; all
  other referrals generally treated the same
 Clinic is able to differentiate conditions
  requiring within 1 month from conditions
  requiring referral within 2 days
What Is The Average Waiting Time For
Eye Care Referrals From Your Clinic?


   Less than one week
   One week to less than one month
   One month to less than three months
   Three months to less than six months
   Six months or more
   I don’t know how long my patients wait to see
    an eye care provider.
The Challenge of Referral for
Other Conditions
 The retinal consult does not take the place
  of a full eye exam.
 Sensitivity and specificity of referral based
  on electronic consults have not been
  validated for other conditions
     Disagreement about when to treat, when to refer
     Excessive variability in consultant
      recommendations
     Less effective treatment
     Excessive over-referral
Scientific Committee
Recommendations:
 Purpose: Identify patients with sight-
  threatening conditions.
 Develop protocol for acquiring necessary
  information and images for consistent and
  easily adapted detection system.
 Retinal image interpretation protocol for
  identifying significant lesions in:
     Optic nerves
     Retinas
     Maculas
Optic Nerve Lesions
   Signs of glaucoma:
     Asymmetric cupping: greater than 0.2 dd cupping difference between the two
        eyes
       Enlarged cup: optic nerve cupping equal to or greater than 0.7
       Rim notch or thinning: notch in or thinning of optic nerve tissue extending to edge
        of the optic nerve or disproportionate thinning of rim tissue in inferior or superior
        sections of optic nerve
       Optic nerve/Splinter hemorrhage: flame shaped hemorrhage near or at the rim or
        in the substance of the cup
       Nerve fiber layer defect (NFLD): NFLD occupying greater than 10 degrees of arc
        in the inferior or superior arcuate areas
       For screening purposes, referable glaucoma is considered sight-threatening,
        well-established glaucoma that is likely to be treated immediately. Low risk
        glaucoma suspects would not be referred from this protocol.
   Prominent pallor:
     pale optic nerve without cupping not previously identified
     pale swelling of segment of optic nerve with or without hemorrhage
   Papilledema:
     swollen, hyperemic disc with blurred margins in one or both eyes
Retinal Lesions
   Moderate/Severe nonproliferative diabetic
    retinopathy (NPDR), as defined by the
    International Clinical Diabetic Retinopathy
    Disease Severity Scale
   Neovascularization
     New vessels or diabetes-related fibrous proliferation
      anywhere
     Vitreous hemorrhage or pre-retinal hemorrhage
   Invasive lesions: eg melanomas
   Neovascularization of the iris
   Active retinitis: active retinal inflammation
   Retinal detachment (recent onset)
Lesions of the Macula
   High-risk drusen (large, soft drusen) especially
    associated with:
     Pigment migration
     Geographic atrophy not involving the foveal center
     Disciform scar or prior chorodial neovascularization
 Macular edema, not clinically significant: hard
  exudates within 2 disc diameters but more than one
  disc diameter from the fovea
 Clinically Significant Macular Edema (CSME): hard
  exudates within one disc diameter of fovea
 Subretinal neovascularization
     subretinal hemorrhage or lipid exudate with hemorrhage
      within the arcades
     wet macular edema-intraretinal hemorrhage involving the
      fovea
     cystoid macular edema with blood in cysts
     subretinal pigment epithelial blood (drusen visible over the
      hemorrhage)
Other Referral Criteria
 Visual Acuity < 20/40
 Acute onset of pain and/or vision loss
 *Intraocular pressures
 *Initiation of systemic treatments
  associated with vision loss:
     Hepatitis C treatment
     Plaquenil / quinine derivatives
     Steroids
         *    Not part of the Prevent Blindness Northern
          California Protocol
PBNC Referral Guideline
   Emergency Referral – 1-2 days:
     papilledema
     recent onset retinal detachment
     neovascularization of the iris
     active retinitis
     subretinal neovascularization
     acute vision loss
     acute onset of pain
PBNC Referral Guideline
   Urgent Referral (within 1 month)
     pale swelling of optic nerve or segment of optic
      nerve (with or without hemorrhage)
     neovascularization
     clinically significant macular edema
     possibly invasive lesion
   Moderately Urgent Referral (within 6 months)
     retinal and optic nerve features blurred in all views,
      with VA less than 20/40
     obvious glaucoma
     moderate to severe non-proliferative diabetic
      retinopathy
     high-risk drusen
PBNC Referral Guideline
   Pass
     clear media; retinal and optic nerve features clear
     optic nerve margins sharp, vessels easily visible,
      pink rim, less than 0.5 dd cup in both eyes
     retinal vessels visible and sharp, normal diameters,
      no hemorrhages or pigmented lesions, minimal
      microanerysms
     foveal reflex present, minimal drusen, no
      hemorrhages, flat or pitted
   Non-Readable
     Unreadable photos will not be used to initiate
      referrals; other screening results will be used instead
Future Efforts
   Validation of protocol
   Primary care provider certification for triage
    purposes
   Automation and integration into electronic
    medical records and referral systems
   Connect treating clinicians with EyePACS
    cases
   Automated patient alerts
   Using retinal images for identification of risk
    factors and biomarkers of systemic disease
   Validation of new technology and automated
    algorithms

More Related Content

DOCX
MANAGEMENT OF DIABETIC RETINOPATHY ( for pharm-d students )
PDF
Eye tech services
PDF
Global Medical Cures™ | Diabetic Retinopathy
PPS
Diabetesand Eye Care
PPT
Diabetes And Eye
PDF
Diabetic retinopathy by Dr. Michael Duplessie
PDF
Plaquenil and retinopathy by dr. michael duplessie ophthalmologist
PPTX
Common eye problem corneal ulcer, glaucoma, cataract, diabetic retinopathy, ...
MANAGEMENT OF DIABETIC RETINOPATHY ( for pharm-d students )
Eye tech services
Global Medical Cures™ | Diabetic Retinopathy
Diabetesand Eye Care
Diabetes And Eye
Diabetic retinopathy by Dr. Michael Duplessie
Plaquenil and retinopathy by dr. michael duplessie ophthalmologist
Common eye problem corneal ulcer, glaucoma, cataract, diabetic retinopathy, ...

What's hot (18)

PDF
Taking Care Of Your Retina
PPT
Night blindness
PPTX
Diabetic Retinopathy - Blood Vessel-Related Condition of the Retina
PDF
Amsler grid, Dr. Michael Duplessie, Eye Doctor
PPTX
Unilateral optic neuropathy? - the value of visual fields
PDF
Ovali diabetic retinopathy laser treatment anti vegf
PPT
Retina Review - Part 2
PDF
An Amalgamation-Based System for Micro aneurysm Detection and Diabetic Retino...
PDF
Glaucoma by Dr. Michael Duplessie Ophthalmologist
KEY
Abc's of vision impairments and communication styles
PPTX
Non-Proliferative vs. Proliferative Diabetic Retinopathy
PPT
Early Detection Of Eye Diseases
PPTX
Eye diseases Expo
PPTX
Visual Diagnoses in the ED
KEY
Abc's of vision impairments and communication styles
PDF
F14 aus diabetes &amp; your eyes
PPT
Clinical approach to optic neuritis
PPTX
Diabetic eye slide share kgmoa april 2016
Taking Care Of Your Retina
Night blindness
Diabetic Retinopathy - Blood Vessel-Related Condition of the Retina
Amsler grid, Dr. Michael Duplessie, Eye Doctor
Unilateral optic neuropathy? - the value of visual fields
Ovali diabetic retinopathy laser treatment anti vegf
Retina Review - Part 2
An Amalgamation-Based System for Micro aneurysm Detection and Diabetic Retino...
Glaucoma by Dr. Michael Duplessie Ophthalmologist
Abc's of vision impairments and communication styles
Non-Proliferative vs. Proliferative Diabetic Retinopathy
Early Detection Of Eye Diseases
Eye diseases Expo
Visual Diagnoses in the ED
Abc's of vision impairments and communication styles
F14 aus diabetes &amp; your eyes
Clinical approach to optic neuritis
Diabetic eye slide share kgmoa april 2016
Ad

Similar to LC 09-2011-Broader Blindness Prevention (20)

PPTX
Diabetic retinopathy
DOCX
19 Objective Structured Clinical Examination (OSCE) Retina.docx
PPTX
Diabetic retinopathy
PPTX
Approach to monocular blindness
PPTX
Diabetic macular edema
PPTX
Diabetic Retinopathy: A Clinical Survival Guide
PPTX
diabetic retinopathy
PPT
visual loss compressed
PPTX
Diabetic retinopathy
PPTX
Management of diabetic retinopathy
PPT
Retinopathy of prematurity
PPS
Dr Somdutt Prasad: Eye Donation Awareness
PPTX
chronic visual Disturbance and visual loss Riyad Banayot.pptx
PPTX
Sudden loss of vision...................
PPT
Retinal disease lecture. Optometry. Optometri.
PPTX
Ophthalmoscopy & otoscopy
PPTX
Approach to fundus camera- Reading and interpretation 2.pptx
PPTX
THE PATIENT WITH DECREASED VISION Classification and Management by Iddi.pptx
PPT
Retinal Emergencies
Diabetic retinopathy
19 Objective Structured Clinical Examination (OSCE) Retina.docx
Diabetic retinopathy
Approach to monocular blindness
Diabetic macular edema
Diabetic Retinopathy: A Clinical Survival Guide
diabetic retinopathy
visual loss compressed
Diabetic retinopathy
Management of diabetic retinopathy
Retinopathy of prematurity
Dr Somdutt Prasad: Eye Donation Awareness
chronic visual Disturbance and visual loss Riyad Banayot.pptx
Sudden loss of vision...................
Retinal disease lecture. Optometry. Optometri.
Ophthalmoscopy & otoscopy
Approach to fundus camera- Reading and interpretation 2.pptx
THE PATIENT WITH DECREASED VISION Classification and Management by Iddi.pptx
Retinal Emergencies
Ad

Recently uploaded (20)

PPTX
Hypertensive disorders in pregnancy.pptx
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PPTX
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
PPTX
Critical Issues in Periodontal Research- An overview
PPTX
Assessment of fetal wellbeing for nurses.
PDF
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
PPTX
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PPTX
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
PPTX
Reading between the Rings: Imaging in Brain Infections
PPT
Rheumatology Member of Royal College of Physicians.ppt
PDF
OSCE Series ( Questions & Answers ) - Set 6.pdf
PPTX
Physiology of Thyroid Hormones.pptx
PPTX
Approach to chest pain, SOB, palpitation and prolonged fever
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PPTX
Wheat allergies and Disease in gastroenterology
PPTX
Vesico ureteric reflux.. Introduction and clinical management
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
Hypertensive disorders in pregnancy.pptx
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
Critical Issues in Periodontal Research- An overview
Assessment of fetal wellbeing for nurses.
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
Neoplasia III.pptxjhghgjhfj fjfhgfgdfdfsrbvhv
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
@K. CLINICAL TRIAL(NEW DRUG DISCOVERY)- KIRTI BHALALA.pptx
Reading between the Rings: Imaging in Brain Infections
Rheumatology Member of Royal College of Physicians.ppt
OSCE Series ( Questions & Answers ) - Set 6.pdf
Physiology of Thyroid Hormones.pptx
Approach to chest pain, SOB, palpitation and prolonged fever
OSCE Series Set 1 ( Questions & Answers ).pdf
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
Wheat allergies and Disease in gastroenterology
Vesico ureteric reflux.. Introduction and clinical management
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha

LC 09-2011-Broader Blindness Prevention

  • 1. Jorge Cuadros OD PhD Tara Seymour
  • 2. Significance of Broader Blindness Prevention in Our Clinics  Diabetic retinopathy is the main cause of blindness in working age adults, but not in all adults.  More people will become blind from macular degeneration and glaucoma.  The majority of blindness could be prevented with early intervention.  Many sight-threatening conditions have been detected and referred through EyePACS
  • 3. EyePACS Referrals  8.21% of all EyePACS consults resulted in referral for sight-threatening diabetic retinopathy  7.83% of all EyePACS consults resulted in referral for other sight-threatening conditions  Glaucoma  Cataract  Maculopathy  Papillopathy (optic nerve)  Pigmented lesions  Retinal degeneration
  • 4. How Does Your Clinic Handle Eye Referrals?  No time frame given – all eye referrals generally treated the same  Urgent referrals (within 2 days) made with sudden decreased vision or ocular pain; all other referrals generally treated the same  Clinic is able to differentiate conditions requiring within 1 month from conditions requiring referral within 2 days
  • 5. What Is The Average Waiting Time For Eye Care Referrals From Your Clinic?  Less than one week  One week to less than one month  One month to less than three months  Three months to less than six months  Six months or more  I don’t know how long my patients wait to see an eye care provider.
  • 6. The Challenge of Referral for Other Conditions  The retinal consult does not take the place of a full eye exam.  Sensitivity and specificity of referral based on electronic consults have not been validated for other conditions  Disagreement about when to treat, when to refer  Excessive variability in consultant recommendations  Less effective treatment  Excessive over-referral
  • 7. Scientific Committee Recommendations:  Purpose: Identify patients with sight- threatening conditions.  Develop protocol for acquiring necessary information and images for consistent and easily adapted detection system.  Retinal image interpretation protocol for identifying significant lesions in:  Optic nerves  Retinas  Maculas
  • 8. Optic Nerve Lesions  Signs of glaucoma:  Asymmetric cupping: greater than 0.2 dd cupping difference between the two eyes  Enlarged cup: optic nerve cupping equal to or greater than 0.7  Rim notch or thinning: notch in or thinning of optic nerve tissue extending to edge of the optic nerve or disproportionate thinning of rim tissue in inferior or superior sections of optic nerve  Optic nerve/Splinter hemorrhage: flame shaped hemorrhage near or at the rim or in the substance of the cup  Nerve fiber layer defect (NFLD): NFLD occupying greater than 10 degrees of arc in the inferior or superior arcuate areas  For screening purposes, referable glaucoma is considered sight-threatening, well-established glaucoma that is likely to be treated immediately. Low risk glaucoma suspects would not be referred from this protocol.  Prominent pallor:  pale optic nerve without cupping not previously identified  pale swelling of segment of optic nerve with or without hemorrhage  Papilledema:  swollen, hyperemic disc with blurred margins in one or both eyes
  • 9. Retinal Lesions  Moderate/Severe nonproliferative diabetic retinopathy (NPDR), as defined by the International Clinical Diabetic Retinopathy Disease Severity Scale  Neovascularization  New vessels or diabetes-related fibrous proliferation anywhere  Vitreous hemorrhage or pre-retinal hemorrhage  Invasive lesions: eg melanomas  Neovascularization of the iris  Active retinitis: active retinal inflammation  Retinal detachment (recent onset)
  • 10. Lesions of the Macula  High-risk drusen (large, soft drusen) especially associated with:  Pigment migration  Geographic atrophy not involving the foveal center  Disciform scar or prior chorodial neovascularization  Macular edema, not clinically significant: hard exudates within 2 disc diameters but more than one disc diameter from the fovea  Clinically Significant Macular Edema (CSME): hard exudates within one disc diameter of fovea  Subretinal neovascularization  subretinal hemorrhage or lipid exudate with hemorrhage within the arcades  wet macular edema-intraretinal hemorrhage involving the fovea  cystoid macular edema with blood in cysts  subretinal pigment epithelial blood (drusen visible over the hemorrhage)
  • 11. Other Referral Criteria  Visual Acuity < 20/40  Acute onset of pain and/or vision loss  *Intraocular pressures  *Initiation of systemic treatments associated with vision loss:  Hepatitis C treatment  Plaquenil / quinine derivatives  Steroids  * Not part of the Prevent Blindness Northern California Protocol
  • 12. PBNC Referral Guideline  Emergency Referral – 1-2 days:  papilledema  recent onset retinal detachment  neovascularization of the iris  active retinitis  subretinal neovascularization  acute vision loss  acute onset of pain
  • 13. PBNC Referral Guideline  Urgent Referral (within 1 month)  pale swelling of optic nerve or segment of optic nerve (with or without hemorrhage)  neovascularization  clinically significant macular edema  possibly invasive lesion  Moderately Urgent Referral (within 6 months)  retinal and optic nerve features blurred in all views, with VA less than 20/40  obvious glaucoma  moderate to severe non-proliferative diabetic retinopathy  high-risk drusen
  • 14. PBNC Referral Guideline  Pass  clear media; retinal and optic nerve features clear  optic nerve margins sharp, vessels easily visible, pink rim, less than 0.5 dd cup in both eyes  retinal vessels visible and sharp, normal diameters, no hemorrhages or pigmented lesions, minimal microanerysms  foveal reflex present, minimal drusen, no hemorrhages, flat or pitted  Non-Readable  Unreadable photos will not be used to initiate referrals; other screening results will be used instead
  • 15. Future Efforts  Validation of protocol  Primary care provider certification for triage purposes  Automation and integration into electronic medical records and referral systems  Connect treating clinicians with EyePACS cases  Automated patient alerts  Using retinal images for identification of risk factors and biomarkers of systemic disease  Validation of new technology and automated algorithms